Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

494 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
Kowdley KV, Bowlus CL, Levy C, Akarca US, Alvares-da-Silva MR, Andreone P, Arrese M, Corpechot C, Francque SM, Heneghan MA, Invernizzi P, Jones D, Kruger FC, Lawitz E, Mayo MJ, Shiffman ML, Swain MG, Valera JM, Vargas V, Vierling JM, Villamil A, Addy C, Dietrich J, Germain JM, Mazain S, Rafailovic D, Taddé B, Miller B, Shu J, Zein CO, Schattenberg JM; ELATIVE Study Investigators’ Group; ELATIVE Study Investigators' Group. Kowdley KV, et al. N Engl J Med. 2024 Feb 29;390(9):795-805. doi: 10.1056/NEJMoa2306185. Epub 2023 Nov 13. N Engl J Med. 2024. PMID: 37962077 Clinical Trial.
A Review of New Concepts in Iron Overload.
Sohal A, Kowdley KV. Sohal A, et al. Among authors: kowdley kv. Gastroenterol Hepatol (N Y). 2024 Feb;20(2):98-107. Gastroenterol Hepatol (N Y). 2024. PMID: 38414914 Free PMC article.
Non-Hispanic Black Persons With Nonalcoholic Fatty Liver Disease Have Lower Rates of Advanced Fibrosis, Cirrhosis, and Liver-Related Events Even After Controlling for Clinical Risk Factors and PNPLA3 Genotype.
Samala N, Xin Y, Wilson LA, Yates K, Loomba R, Hoofnagle JH, Chalasani N; NASH Clinical Research Network. Samala N, et al. Am J Gastroenterol. 2024 Sep 1;119(9):1857-1865. doi: 10.14309/ajg.0000000000002756. Epub 2024 May 14. Am J Gastroenterol. 2024. PMID: 38483303
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?
Jones DEJ, Beuers U, Bonder A, Carbone M, Culver E, Dyson J, Gish RG, Hansen BE, Hirschfield G, Jones R, Kowdley K, Kremer AE, Lindor K, Mayo M, Mells G, Neuberger J, Prince M, Swain M, Tanaka A, Thorburn D, Trauner M, Trivedi P, Weltman M, Yeoman A, Levy C. Jones DEJ, et al. Hepatology. 2024 Nov 1;80(5):1291-1300. doi: 10.1097/HEP.0000000000000864. Epub 2024 Mar 22. Hepatology. 2024. PMID: 38506926 Free PMC article.
A Rare Case of Tirzepatide-Induced Hepatotoxicity.
Sohal A, Casanova L, Kowdley KV. Sohal A, et al. Among authors: kowdley kv. ACG Case Rep J. 2024 Oct 4;11(10):e01484. doi: 10.14309/crj.0000000000001484. eCollection 2024 Oct. ACG Case Rep J. 2024. PMID: 39372916 Free PMC article.
494 results